716 related articles for article (PubMed ID: 16967455)
41. Improving the accuracy of TNM staging in esophageal cancer: a pathological review of resected specimens.
Thompson SK; Ruszkiewicz AR; Jamieson GG; Esterman A; Watson DI; Wijnhoven BP; Lamb PJ; Devitt PG
Ann Surg Oncol; 2008 Dec; 15(12):3447-58. PubMed ID: 18830669
[TBL] [Abstract][Full Text] [Related]
42. [The patterns and prognostic factors of abdominal lymph node metastasis in patients with the middle thoracic esophageal squamous cell carcinoma].
Wang Z; Liu XY; Liu FY
Zhonghua Wai Ke Za Zhi; 2008 Dec; 46(23):1800-3. PubMed ID: 19094790
[TBL] [Abstract][Full Text] [Related]
43. The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma.
Waterman TA; Hagen JA; Peters JH; DeMeester SR; Taylor CR; Demeester TR
Ann Thorac Surg; 2004 Oct; 78(4):1161-9; discussion 1161-9. PubMed ID: 15464464
[TBL] [Abstract][Full Text] [Related]
44. The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system.
Rizk N; Venkatraman E; Park B; Flores R; Bains MS; Rusch V;
J Thorac Cardiovasc Surg; 2006 Dec; 132(6):1374-81. PubMed ID: 17140960
[TBL] [Abstract][Full Text] [Related]
45. Impact of lymph node involvement in T2 or T3 thoracic esophageal squamous cell carcinoma.
Shimada H; Okazumi S; Shiratori T; Akutsu Y; Matsubara H
Hepatogastroenterology; 2009; 56(93):1039-43. PubMed ID: 19760937
[TBL] [Abstract][Full Text] [Related]
46. Pathologic prognostic factors in Barrett's associated adenocarcinoma: a follow-up study of 96 patients.
Torres C; Turner JR; Wang HH; Richards W; Sugarbaker D; Shahsafaei A; Odze RD
Cancer; 1999 Feb; 85(3):520-8. PubMed ID: 10091725
[TBL] [Abstract][Full Text] [Related]
47. An evaluation of the number of lymph nodes examined and survival for node-negative esophageal carcinoma: data from China.
Yang HX; Xu Y; Fu JH; Wang JY; Lin P; Rong TH
Ann Surg Oncol; 2010 Jul; 17(7):1901-11. PubMed ID: 20146101
[TBL] [Abstract][Full Text] [Related]
48. [Cox proportional hazard model analysis of prognosis in patients with carcinoma of esophagus and gastric cardia after radical resection].
Liu W; Hao XS; Fan Q; Li HX; Song LN; Wang SJ; Wang PZ; Jin Y; Chen Y; Guan LY; Ping YM; Meng XL; Wang R; Liu JF; Wang XL
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):921-5. PubMed ID: 19173994
[TBL] [Abstract][Full Text] [Related]
49. [Clinical implications of the new TNM staging system for thoracic esophageal squamous cell carcinoma].
Fang WT; Feng J; Mao T; Fu SJ; Chen WH
Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):687-91. PubMed ID: 22340051
[TBL] [Abstract][Full Text] [Related]
50. Prognostic significance of the carcinoma area in the thickest part of the lymph node.
Doi N; Imada T; Aoyama N; Kameda Y; Koizumi H
Hepatogastroenterology; 2000; 47(33):728-32. PubMed ID: 10919020
[TBL] [Abstract][Full Text] [Related]
51. Impact of number and site of lymph node invasion on survival of adenocarcinoma of esophagogastric junction.
Ielpo B; Pernaute AS; Elia S; Buonomo OC; Valladares LD; Aguirre EP; Petrella G; Garcia AT
Interact Cardiovasc Thorac Surg; 2010 May; 10(5):704-8. PubMed ID: 20154347
[TBL] [Abstract][Full Text] [Related]
52. Developing an appropriate staging system for esophageal carcinoma.
Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono HA; Shimada H
J Am Coll Surg; 2005 Dec; 201(6):884-90. PubMed ID: 16310691
[TBL] [Abstract][Full Text] [Related]
53. Prognostic relevance of histomorphological parameters and DNA content and their therapeutic consequences in esophageal carcinoma: a multivariate approach.
Boettger T; Dutkowski P; Kirkpatrick CJ; Seifert JK; Junginger T
Hepatogastroenterology; 1998; 45(22):994-1004. PubMed ID: 9755996
[TBL] [Abstract][Full Text] [Related]
54. Prediction of lymph node status in superficial esophageal carcinoma.
Ancona E; Rampado S; Cassaro M; Battaglia G; Ruol A; Castoro C; Portale G; Cavallin F; Rugge M
Ann Surg Oncol; 2008 Nov; 15(11):3278-88. PubMed ID: 18726651
[TBL] [Abstract][Full Text] [Related]
55. Prediction of lymph node status in patients with superficial esophageal carcinoma: analysis of 160 surgically resected cancers.
Shimada H; Nabeya Y; Matsubara H; Okazumi S; Shiratori T; Shimizu T; Aoki T; Shuto K; Akutsu Y; Ochiai T
Am J Surg; 2006 Feb; 191(2):250-4. PubMed ID: 16442955
[TBL] [Abstract][Full Text] [Related]
56. Survival after esophageal resection for carcinoma: the importance of the histologic cell type.
Alexiou C; Khan OA; Black E; Field ML; Onyeaka P; Beggs L; Duffy JP; Beggs DF
Ann Thorac Surg; 2006 Sep; 82(3):1073-7. PubMed ID: 16928541
[TBL] [Abstract][Full Text] [Related]
57. The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomas.
Brücher BL; Becker K; Lordick F; Fink U; Sarbia M; Stein H; Busch R; Zimmermann F; Molls M; Höfler H; Siewert JR
Cancer; 2006 May; 106(10):2119-27. PubMed ID: 16607651
[TBL] [Abstract][Full Text] [Related]
58. [Clinicopathologic features and prognostic factors of cervical lymph node metastasis in oral squamous cell carcinoma].
Li XM; DI B; Shang YD; Li J; Cheng JM
Ai Zheng; 2005 Feb; 24(2):208-12. PubMed ID: 15694035
[TBL] [Abstract][Full Text] [Related]
59. Prognostic impact of upper, middle, and lower third mucosal or submucosal infiltration in early esophageal cancer.
Hölscher AH; Bollschweiler E; Schröder W; Metzger R; Gutschow C; Drebber U
Ann Surg; 2011 Nov; 254(5):802-7; discussion 807-8. PubMed ID: 22042472
[TBL] [Abstract][Full Text] [Related]
60. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
